Anti-programmed death ligand 1 (PD-L1) inhibitors in metastatic gastric cancer

Metastatic gastric cancer (GC) with limited therapeutic options has a poor prognosis, and therefore, major therapeutic advances are needed. Comprehensive genomic characterization has improved understanding of GC but a great majority of genomic profiling has not been effectively translated to the cli...

Full description

Bibliographic Details

Published in:	Precision and Future Medicine
Main Authors:	Jang Ho Cho, Jeeyun Lee
Format:	Article
Language:	English
Published:	Sungkyunkwan University School of Medi 2017-12-01
Subjects:	Gastric Immune checkpoint Neoplasms Programmed cell death protein 1 Programmed death ligand 1
Online Access:	http://www.pfmjournal.org/upload/pdf/pfm-2017-00177.pdf